SPC
ZYME icon

Sigma Planning Corp’s Zymeworks ZYME Stock Holding History

Sigma Planning Corp’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,416
Closed -$256K – 1417
2020
Q4 		$256K Buy
5,416
+47
+0.9% +$2.18K 0.01% 983
2020
Q3 		$250K Buy
+5,369
New +$184K 0.01% 864

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sigma Planning Corp's ZYME Position: Q1 2021 in Review

Sigma Planning Corp sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 5,416 shares — an estimated $256K sold.

Sigma Planning Corp first reported a position in ZYME in Q3 2020 and held it in 2 quarters. The position peaked at $256K in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Sigma Planning Corp reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Sigma Planning Corp sold 5,416 Zymeworks shares in Q1 2021, an estimated $256K.
  • Sigma Planning Corp first reported a position in Zymeworks in Q3 2020 and held it in 2 quarters.
  • Sigma Planning Corp's Zymeworks position peaked at $256K in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Sigma Planning Corp's 13F filing for Q1 2021, filed 6 May 2021.